Meanwhile, the overlapping pathways between SS and NASH were PI3K-Akt signaling pathway and pathways in cancer, suggesting that the two pathways could be an important therapeutic target for NAFLD. This evidence concerns the gene AKT1 and metabolic dysfunction-associated steatotic liver disease.